Matches in Wikidata for { <http://www.wikidata.org/entity/Q91006190> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q91006190 description "article scientifique publié en 2018" @default.
- Q91006190 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q91006190 description "im Juli 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91006190 description "scientific article published on 01 July 2018" @default.
- Q91006190 description "wetenschappelijk artikel" @default.
- Q91006190 description "наукова стаття, опублікована в липні 2018" @default.
- Q91006190 name "Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma" @default.
- Q91006190 name "Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma" @default.
- Q91006190 type Item @default.
- Q91006190 label "Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma" @default.
- Q91006190 label "Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma" @default.
- Q91006190 prefLabel "Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma" @default.
- Q91006190 prefLabel "Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma" @default.
- Q91006190 P1433 Q91006190-149C02C1-6B2A-44D2-A7E1-24C417E0A819 @default.
- Q91006190 P1476 Q91006190-0303252E-FE94-4135-8838-5F1E9EF99D5E @default.
- Q91006190 P2093 Q91006190-68FD1ECC-2365-43BE-97AE-EFEA6D82541E @default.
- Q91006190 P2093 Q91006190-F608196D-5042-4774-98C1-0516D85E0DB4 @default.
- Q91006190 P2860 Q91006190-0F797741-82E9-4E9E-83B5-B29023E6C5FE @default.
- Q91006190 P2860 Q91006190-3082F332-6576-46A9-8118-F3F703A3FDC3 @default.
- Q91006190 P2860 Q91006190-6BBFB933-3B5F-4F6B-8F9F-B73B19A85661 @default.
- Q91006190 P304 Q91006190-786880C0-A1F4-4978-A026-674E01BBED69 @default.
- Q91006190 P31 Q91006190-4AE10136-259F-4335-B3BE-4F362A1A9EC6 @default.
- Q91006190 P356 Q91006190-542998A5-8659-4A21-AFC1-6EBAB30B37FA @default.
- Q91006190 P433 Q91006190-CA05EF1B-807E-49F0-849E-5E74AFE6ACD7 @default.
- Q91006190 P478 Q91006190-579C758D-6D7C-42A1-B741-15CF93D723A3 @default.
- Q91006190 P577 Q91006190-D31EC615-0BEE-4E30-8F29-9FAFCB981295 @default.
- Q91006190 P698 Q91006190-24B2E541-5697-4B55-B9E8-650A0EA3103D @default.
- Q91006190 P921 Q91006190-3CE2553B-3BC8-41BD-83CD-9F5E86A6D9FE @default.
- Q91006190 P921 Q91006190-9D58037D-EAF3-49B0-AFC1-E14E54A9AFE9 @default.
- Q91006190 P356 PPO.0000000000000323 @default.
- Q91006190 P698 30119080 @default.
- Q91006190 P1433 Q2589130 @default.
- Q91006190 P1476 "Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma" @default.
- Q91006190 P2093 "David F McDermott" @default.
- Q91006190 P2093 "Xin Gao" @default.
- Q91006190 P2860 Q22009936 @default.
- Q91006190 P2860 Q37422116 @default.
- Q91006190 P2860 Q42806703 @default.
- Q91006190 P304 "171-179" @default.
- Q91006190 P31 Q13442814 @default.
- Q91006190 P356 "10.1097/PPO.0000000000000323" @default.
- Q91006190 P433 "4" @default.
- Q91006190 P478 "24" @default.
- Q91006190 P577 "2018-07-01T00:00:00Z" @default.
- Q91006190 P698 "30119080" @default.
- Q91006190 P921 Q1164529 @default.
- Q91006190 P921 Q413299 @default.